Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Analysis of Compositional Bias in a Commercial Phage Display Peptide Library by Next-Generation Sequencing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Special Issue "HPV in the Head and Neck Region"

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  1. Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

We report the in vitro efficacy of ion-channel inhibitors amantadine, memantine and rimantadine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In VeroE6 cells, rimantadine was most potent followed by memantine and amantadine (50% effective concentrations: 36, 80 and 116 µM, respectively). Rimantadine also showed the highest selectivity index, followed by amantadine and memantine (17.3, 12.2 and 7.6, respectively). Similar results were observed in human hepatoma Huh7.5 and lung carcinoma A549-hACE2 cells. Inhibitors interacted in a similar antagonistic manner with remdesivir and had a similar barrier to viral escape. Rimantadine acted mainly at the viral post-entry level and partially at the viral entry level. Based on these results, rimantadine showed the most promise for treatment of SARS-CoV-2.

OriginalsprogEngelsk
Artikelnummer2082
TidsskriftViruses
Vol/bind13
Udgave nummer10
Sider (fra-til)1-11
Antal sider11
ISSN1999-4915
DOI
StatusUdgivet - 15 okt. 2021

ID: 68561622